Isidro Machado1, Lara Navarro2, Antonio Pellin2, Samuel Navarro2, Abbas Agaimy3, Juan C Tardío4, Apollon Karseladze5, Semyon Petrov6, Katia Scotlandi7, Piero Picci7, Antonio Llombart-Bosch2. 1. Instituto Valenciano de Oncología (FIVO), Pathology Dept, Valencia,Spain. Electronic address: isidro.machado@uv.es. 2. University of Valencia, Pathology Dept, Valencia, Valencia, Spain. 3. Friedrich Alexander University Erlangen-Nuremberg, Institute of Pathology, University Hospital, Erlangen, Germany. 4. Hospital Universitario de Fuenlabrada, Pathology Dept, Madrid, Spain. 5. All Cancer Center, Pathology Dept, Moscow, Russian Federation. 6. Cancer Center, Pathology Dept and Kazan State Medical University, Pathology Dept, Kazan, Russian Federation. 7. Rizzoli Inst, Laboratory of Experimental Oncology, Bologna, Italy.
Abstract
BACKGROUND: Differentiation of Ewing sarcoma family of tumors (ESFT) and Ewing-like tumors remains problematic. Certain ESFT with morphological and immunohistochemical (IHC) profiles lack the EWSR1-ETS transcript. To improve diagnostic accuracy we investigated the presence of several specific transcripts in 200 small round cell tumors (SRCT) displaying ESFT morphology and immunophenotype in which EWSR1 FISH analysis was non-informative or negative. DESIGN: 200 tumors (formalin-fixed, paraffin-embedded) were analyzed by RT-PCR. All tumors were tested for EWSR1-ETS, EWSR1/WT1, PAX3/7-FOX01 or SYT/SSX transcripts, and the negative tumors were subsequently analyzed for CIC/DUX4, BCOR/CCNB3 and CIC/FOX04 transcripts. RESULTS: 133 (66.5%) ESFT displayed one of the above EWSR1-ETS translocations. Three cases (1.5%) revealed the SYT-SSX transcript for Synovial sarcoma, and one (0.5%) a EWSR1-WT1 transcript for Desmoplastic Small Round Cell tumor. The CIC-DUX4 translocation was found in six Ewing-like tumors (3%) with CD99 positivity. The BCOR-CCNB3 gene fusion was observed in 5 tumors (2.5%) displaying round or spindle cells with strong CCNB3 IHC expression in 3 tumors. Moreover, RT-PCR failed to detect any gene fusion transcripts in 19 tumors (9.5%) and were considered "undifferentiated small round cell sarcoma" (SRCS). Molecular biology results were non-informative in 33 SRCTs (16.5%) due to RNA degradation through inadequate fixation and/or decalcification. CONCLUSION: Our analysis of 200 SRCTs confirms the molecular heterogeneity of neoplasms with ESFT morphology and highlight that molecular studies with RT-PCR including new emerging gene fusion transcripts are mandatory for the diagnosis when EWSR1 FISH is negative or non-informative. The incidence of CIC-DUX4, BCOR-CCNB3 and CIC-FOX04 transcripts was relatively low. A small group of Ewing-like sarcomas or undifferentiated SRCS remains unclassified. Adopting appropriate tissue fixation and processing protocols is important to avoid degradation of fixed/embedded tissue when no frozen tumor is available.
BACKGROUND: Differentiation of Ewing sarcoma family of tumors (ESFT) and Ewing-like tumors remains problematic. Certain ESFT with morphological and immunohistochemical (IHC) profiles lack the EWSR1-ETS transcript. To improve diagnostic accuracy we investigated the presence of several specific transcripts in 200 small round cell tumors (SRCT) displaying ESFT morphology and immunophenotype in which EWSR1 FISH analysis was non-informative or negative. DESIGN: 200 tumors (formalin-fixed, paraffin-embedded) were analyzed by RT-PCR. All tumors were tested for EWSR1-ETS, EWSR1/WT1, PAX3/7-FOX01 or SYT/SSX transcripts, and the negative tumors were subsequently analyzed for CIC/DUX4, BCOR/CCNB3 and CIC/FOX04 transcripts. RESULTS: 133 (66.5%) ESFT displayed one of the above EWSR1-ETS translocations. Three cases (1.5%) revealed the SYT-SSX transcript for Synovial sarcoma, and one (0.5%) a EWSR1-WT1 transcript for Desmoplastic Small Round Cell tumor. The CIC-DUX4 translocation was found in six Ewing-like tumors (3%) with CD99 positivity. The BCOR-CCNB3 gene fusion was observed in 5 tumors (2.5%) displaying round or spindle cells with strong CCNB3 IHC expression in 3 tumors. Moreover, RT-PCR failed to detect any gene fusion transcripts in 19 tumors (9.5%) and were considered "undifferentiated small round cell sarcoma" (SRCS). Molecular biology results were non-informative in 33 SRCTs (16.5%) due to RNA degradation through inadequate fixation and/or decalcification. CONCLUSION: Our analysis of 200 SRCTs confirms the molecular heterogeneity of neoplasms with ESFT morphology and highlight that molecular studies with RT-PCR including new emerging gene fusion transcripts are mandatory for the diagnosis when EWSR1 FISH is negative or non-informative. The incidence of CIC-DUX4, BCOR-CCNB3 and CIC-FOX04 transcripts was relatively low. A small group of Ewing-like sarcomas or undifferentiated SRCS remains unclassified. Adopting appropriate tissue fixation and processing protocols is important to avoid degradation of fixed/embedded tissue when no frozen tumor is available.
Authors: Steven G DuBois; Mark D Krailo; Allen Buxton; Stephen L Lessnick; Lisa A Teot; Dinesh Rakheja; Brian D Crompton; Katherine A Janeway; Richard G Gorlick; Julia Glade-Bender Journal: Arch Pathol Lab Med Date: 2021-12-01 Impact factor: 5.686
Authors: Michael D Kinnaman; Chong Zhu; Daniel A Weiser; Sana Mohiuddin; Pooja Hingorani; Michael Roth; Jonathan Gill; Katherine A Janeway; Richard Gorlick; Stephen L Lessnick; Patrick J Grohar Journal: Sarcoma Date: 2020-12-05
Authors: Celso Abdon Mello; Fernando Augusto Batista Campos; Tiago Goss Santos; Maria Leticia Gobo Silva; Giovana Tardin Torrezan; Felipe D'Almeida Costa; Maria Nirvana Formiga; Ulisses Nicolau; Antonio Geraldo Nascimento; Cassia Silva; Maria Paula Curado; Suely Akiko Nakagawa; Ademar Lopes; Samuel Aguiar Journal: Cancers (Basel) Date: 2021-01-28 Impact factor: 6.639
Authors: Michaela C Baldauf; Martin F Orth; Marlene Dallmayer; Aruna Marchetto; Julia S Gerke; Rebeca Alba Rubio; Merve M Kiran; Julian Musa; Maximilian M L Knott; Shunya Ohmura; Jing Li; Nusret Akpolat; Ayse N Akatli; Özlem Özen; Uta Dirksen; Wolfgang Hartmann; Enrique de Alava; Daniel Baumhoer; Giuseppina Sannino; Thomas Kirchner; Thomas G P Grünewald Journal: Oncotarget Date: 2017-08-04
Authors: Salvatore Pisconti; Giuseppina Della Vittoria Scarpati; Carlo Buonerba; Simona Messinese; Roberta Carella; Massimiliano Di Marzo; Giuseppe Di Lorenzo; Grazia Lazzari; Francesco Perri; Raffaele Solla Journal: Onco Targets Ther Date: 2020-02-14 Impact factor: 4.147